Paul Nguyen shared a post on X:
”NRG GU-009/PREDICT-RT Intensification Arms completed accrual yesterday, 2 years ahead of schedule! Thank you NRG Oncology GU investigators and patients and let’s keep up the great momentum to accrue the De-Intensification Arms (24 vs 12 months ADT) over the next year!”
Source: Paul Nguyen/X
Paul Nguyen is a Medical Advisor at Nanocan Therapeutics Corporation and Boston Scientific. He has been with Dana-Farber Cancer Institute for over 19 years, serving as Director of Genitourinary Radiation Oncology, Professor, and Vice-Chair of Clinical Research. He is also a Professor of Radiation Oncology at Harvard Medical School.